|
|
Volumn 14, Issue 2, 2014, Pages 139-140
|
|
Differing standards for the NIH stem cell registry and FDA approval render most federally funded hESC lines unsuitable for clinical Use
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELL LINE;
CLINICAL TRIAL (TOPIC);
CYTOLOGY;
EMBRYONIC STEM CELL;
ETHICS;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LEGISLATION AND JURISPRUDENCE;
NATIONAL HEALTH ORGANIZATION;
REGISTER;
STANDARDS;
STEM CELL RESEARCH;
UNITED STATES;
CELL LINE;
CLINICAL TRIALS AS TOPIC;
EMBRYONIC STEM CELLS;
FINANCING, GOVERNMENT;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
REGISTRIES;
STEM CELL RESEARCH;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84893733307
PISSN: 19345909
EISSN: 18759777
Source Type: Journal
DOI: 10.1016/j.stem.2013.12.014 Document Type: Letter |
|
Times cited : (13)
|
|
References (4)
|
